Janus Henderson Group PLC Buys Shares of 30,334 Electromed, Inc. (NYSE:ELMD)

Janus Henderson Group PLC bought a new position in Electromed, Inc. (NYSE:ELMD - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 30,334 shares of the company's stock, valued at approximately $896,000. Janus Henderson Group PLC owned about 0.36% of Electromed as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. Arrowstreet Capital Limited Partnership grew its holdings in shares of Electromed by 261.0% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 114,579 shares of the company's stock worth $3,386,000 after purchasing an additional 82,839 shares during the last quarter. Northern Trust Corp grew its holdings in shares of Electromed by 14.1% in the 4th quarter. Northern Trust Corp now owns 65,350 shares of the company's stock worth $1,931,000 after purchasing an additional 8,086 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Electromed in the 4th quarter worth about $1,760,000. Susquehanna International Group LLP grew its holdings in shares of Electromed by 121.8% in the 4th quarter. Susquehanna International Group LLP now owns 56,726 shares of the company's stock worth $1,676,000 after purchasing an additional 31,148 shares during the last quarter. Finally, Navellier & Associates Inc. grew its holdings in Electromed by 228.5% during the 4th quarter. Navellier & Associates Inc. now owns 56,368 shares of the company's stock worth $1,666,000 after acquiring an additional 39,208 shares during the last quarter. Institutional investors own 40.82% of the company's stock.

Electromed Stock Up 0.1%

NYSE:ELMD traded up $0.02 during mid-day trading on Thursday, reaching $20.35. 3,400 shares of the company were exchanged, compared to its average volume of 86,512. Electromed, Inc. has a 12 month low of $13.74 and a 12 month high of $35.56. The company has a fifty day moving average of $22.45 and a 200 day moving average of $27.10. The stock has a market cap of $170.66 million, a PE ratio of 27.13 and a beta of 0.46.

Electromed declared that its board has initiated a share repurchase plan on Monday, March 10th that allows the company to buyback $5.00 million in outstanding shares. This buyback authorization allows the company to repurchase up to 2.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

ELMD has been the topic of a number of research analyst reports. B. Riley raised shares of Electromed to a "strong-buy" rating in a report on Thursday, May 15th. Wall Street Zen lowered shares of Electromed from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 8th.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.